[Why perform PCI of coronary chronic occlusion and how?]

Y Louvard1, T Lefèvre

  • 1Institut cardiovasculaire Paris Sud, institut hospitalier Jacques-Cartier, 6, rue du Noyer-Lambert, 91300 Massy, France. y.louvard@icps.com.fr

Annales De Cardiologie Et D'Angeiologie
|November 7, 2008
PubMed

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) is now more successful due to advanced techniques and devices. Successful CTO PCI improves heart function, symptoms, and survival, while reducing future cardiac event risks.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine

Context:

  • Coronary chronic total occlusions (CTOs), defined as occluded vessels with TIMI 0 flow for over 3 months, were historically challenging for angioplasty.
  • Previous low success and high restenosis rates led to medical management or surgical referral for CTOs.

Purpose:

  • To review the advancements in percutaneous coronary intervention (PCI) for CTOs.
  • To discuss the improved outcomes and patient selection criteria for CTO PCI.

Summary:

  • Significant advancements in devices and techniques have dramatically increased CTO PCI success rates to 70-90% in experienced hands.
  • Successful CTO recanalization improves myocardial ischemia, left ventricular function, symptoms, and patient survival.
  • Key factors for successful PCI include lesion characteristics, operator expertise, and assessment of myocardial viability (e.g., MRI).
  • Specific devices and techniques, including antegrade and retrograde approaches, enhance CTO recanalization success.

Impact:

  • CTO PCI can decrease the risk of death and cardiogenic shock from future acute coronary events.
  • While challenges like radiation exposure and contrast volume exist, improved success rates justify specialized operator performance.
  • Successful CTO PCI offers a viable alternative to medical management or surgery, improving patient prognosis.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...